InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: None

Monday, 11/22/2021 8:53:14 AM

Monday, November 22, 2021 8:53:14 AM

Post# of 426486
Novartis plans new sales approach for cholesterol lowering drug - WSJ

https://seekingalpha.com/news/3773170-novartis-plans-new-sales-approach-for-cholesterol-lowering-drug-wsj

https://www.wsj.com/articles/novartis-rethinks-sales-strategy-for-new-cholesterol-drug-launch-11637510400?mod=pls_whats_news_us_business_f

Note that Novartis' drug has not yet gain US approval and is still waiting for its outcome data.

I think AMRN should copy NVS's approach (NVS target LDL level) using electronic health records targeting TG>150 mg/dL level.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News